These drug corporations – the same ones whose actions have cost the lives of more than 750,000 Americans and counting from the opioid epidemic – are now finding ways to reduce their settlements, and leaving taxpayers to make up the difference.
It is disappointing, but sadly not surprising, that in the middle of a global pandemic and economic downturn, Republicans on the Energy & Commerce Committee just voted unanimously against holding Big Pharma accountable for raising prices faster than inflation for patients in Medicaid.
By Margarida Jorge and Niko Lusiani
In his first weeks on the job, President Joe Biden has put forward numerous executive orders that show his administration’s commitment to returning the U.S. to a leadership role in the global response to COVID-19. This new approach reflects a clear lesson from the Trump administration’s failed example: We cannot succeed by going it alone.
…
U.S. Sen. Elizabeth Warren (D-MA) and Rep. Jan Schakowsky (D-IL) introduced legislation to publicly manufacture personal protective equipment, prescription drugs, and other medical supplies necessary to fight the COVID-19 pandemic.
The Pandemic Emergency Manufacturing Act of 2021 authorizes the federal government to manufacture medical products,
…
Today, Congresswoman Jan Schakowsky (D-IL) and Democratic colleagues reintroduced legislation to strengthen oversight of federal funds invested in COVID-19 research and development, and to protect patients from being price-gouged on COVID-19 treatments and vaccines developed with taxpayer dollars.
Today, UnidosUS Action Fund and Lower Drug Prices Now released a new report, A Vicious Cycle of Health Inequity, that highlights the disproportionate impact of high prescription drug prices on Latinos in the US, and shows that Latinos overwhelmingly want their elected leaders to take action to lower drug costs.
Each day that goes by, it becomes clearer that urgent action is needed to lower the price of prescription drugs. Americans pay too much for prescription medicines whether out-of-pocket at the pharmacy, through high health insurance premiums, or through taxes to help pay for Medicare as well as an array of tax breaks for the prescription drug industry.
